SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-036208
Filing Date
2020-08-04
Accepted
2020-08-04 18:04:33
Documents
5
Period of Report
2020-08-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K achv-8k_20200803.htm 8-K 44354
2 EX-1.1 achv-ex11_10.htm EX-1.1 255414
3 EX-4.1 achv-ex41_11.htm EX-4.1 84803
4 EX-5.1 achv-ex51_6.htm EX-5.1 18538
5 GRAPHIC gdsgakqbhf23000001.jpg GRAPHIC 8409
  Complete submission text file 0001564590-20-036208.txt   416200
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 201074611
SIC: 2835 In Vitro & In Vivo Diagnostic Substances